The opioid crisis ravaging the country of its full potential demands a multi-faceted approach. To help strengthen the disposal process for dangerous opioids, Senator Braun joined Senator Maggie Hassan of New Hampshire in introducing the Better ODDS to Reduce Diversion Act of 2021 (S. 2628). This bill authorizes the U.S. Food and Drug Administration (FDA) to direct safe disposal requirements as a part of a Risk Evaluation and Mitigation Strategy (REMS) for a drug, including prescription opioids. Currently, the FDA is only able to recommend the use of mail-in drug disposal products for prescription drugs, such as opioids. This legislation eliminates this burdensome requirement and allows for a broader use of safe and effective at-home, in-home disposal products. This includes products that modify the chemical makeup of the prescription drug to make the drug unusable, or unable to be diverted into a different substance. At a Senate HELP Committee markup held in June 2022, the Better ODDS Act was incorporated into the base text of a bigger legislative package to reauthorize the FDA user fee model (S. 4348, the Food and Drug Administration Safety and Landmark Advancements Act). President Biden subsequently signed this key reform into law on December 29, 2022.